You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

Details for Patent: 11,564,926


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,564,926 protect, and when does it expire?

Patent 11,564,926 protects REZDIFFRA and is included in one NDA.

This patent has sixty-six patent family members in twenty-one countries.


Drugs Protected by US Patent 11,564,926

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Madrigal REZDIFFRA resmetirom TABLET;ORAL 217785-001 Mar 14, 2024 RX Yes No ⤷  Sign Up ⤷  Sign Up Y Y TREATMENT OF ADULTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED LIVER FIBROSIS (CONSISTENT WITH STAGES F2 TO F3 FIBROSIS) ⤷  Sign Up
Madrigal REZDIFFRA resmetirom TABLET;ORAL 217785-002 Mar 14, 2024 RX Yes No ⤷  Sign Up ⤷  Sign Up Y Y TREATMENT OF ADULTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED LIVER FIBROSIS (CONSISTENT WITH STAGES F2 TO F3 FIBROSIS) ⤷  Sign Up
Madrigal REZDIFFRA resmetirom TABLET;ORAL 217785-003 Mar 14, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y TREATMENT OF ADULTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED LIVER FIBROSIS (CONSISTENT WITH STAGES F2 TO F3 FIBROSIS) ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,564,926

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 092872 ⤷  Sign Up
Australia 2013315017 ⤷  Sign Up
Brazil 112015005891 ⤷  Sign Up
Brazil 122021024202 ⤷  Sign Up
Canada 2884481 ⤷  Sign Up
Canada 3090070 ⤷  Sign Up
Canada 3111317 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.